E-LIB Suche - Ergebnisse für: Madin-Warburton, Matthew

1

Cost-effectiveness of pembrolizumab for previously treated ..:

McCarthy, Grant ; Young, Kate ; Madin-Warburton, Matthew...
Journal of Medical Economics. 27 (2024) 1 - p. 279-291 , 2024

Link: https://doi.org/10.1080/..

2

Recent advances in addressing the market failure of new ant..:

Schurer, Marieke ; Patel, Renu ; van Keep, Marjolijn...
Frontiers in Medical Technology. 5 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

3

The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel..:

Chaudhuri, K. Ray ; Pickard, A. Simon ; Alobaidi, Ali...
PharmacoEconomics. 40 (2022) 5 - p. 559-574 , 2022

Link: https://doi.org/10.1007/..

4

Burden of Clostridioides difficile infection (CDI) - a syst..:

Finn, Elaine ; Andersson, Fredrik L. ; Madin-Warburton, Matthew
BMC Infectious Diseases. 21 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

5

1427. A Dynamic Modeling Study of the Effect of Introducing..:

Madin-Warburton, Matthew ; Pitcher, Ashley B ; Kyaw, Moe H.
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S440-S441 , 2018

Link: https://doi.org/10.1093/..

6

Cost-Effectiveness Analysis of Regorafenib for Gastrointest..:

Tamoschus, David ; Draexler, Katja ; Chang, Jane...
Clinical Drug Investigation. 37 (2017) 6 - p. 525-533 , 2017

Link: https://doi.org/10.1007/..

7

Benchmarking the Cost per Person of Mass Treatment for Sele..:

Fitzpatrick, Christopher ; Fleming, Fiona M. ; Madin-Warburton, Matthew...
PLOS Neglected Tropical Diseases. 10 (2016) 12 - p. e0005037 , 2016

Link: https://doi.org/10.1371/..

8

Recent advances in addressing the market failure of new ant..:

Schurer, Marieke ; Patel, Renu ; van Keep, Marjolijn...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969890/. , 2023

Link: http://www.ncbi.nlm.nih...

9

The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel..:

Chaudhuri, K. Ray ; Pickard, A. Simon ; Alobaidi, Ali...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095547/. , 2022

Link: http://www.ncbi.nlm.nih...

10

1427. A Dynamic Modeling Study of the Effect of Introducing..:

Madin-Warburton, Matthew ; Pitcher, Ashley B ; Kyaw, Moe H.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253574/. , 2018

Link: http://www.ncbi.nlm.nih...

11

Cost-effectiveness of pembrolizumab for previously treated ..:

Grant McCarthy ; Kate Young ; Matthew Madin-Warburton...
doi:10.6084/m9.figshare.25117347.v1. , 2024

Link: https://doi.org/10.6084/..

12

Cost-effectiveness of pembrolizumab for previously treated ..:

Grant McCarthy ; Kate Young ; Matthew Madin-Warburton...
doi:10.6084/m9.figshare.25117347.v1. , 2024

Link: https://doi.org/10.6084/..

13

Datasheet1_Recent advances in addressing the market failure..:

Marieke Schurer ; Renu Patel ; Marjolijn van Keep...
doi:10.3389/fmedt.2023.1010247.s001. , 2023

Link: https://doi.org/10.3389/..

14

Recent advances in addressing the market failure of new ant..:

Marieke Schurer ; Renu Patel ; Marjolijn van Keep...
https://www.frontiersin.org/articles/10.3389/fmedt.2023.1010247/full. , 2023

Link: https://doi.org/10.3389/..

15

Burden of Clostridioides difficile infection (CDI) - a syst..:

Elaine Finn ; Fredrik L. Andersson ; Matthew Madin-Warburton
https://doi.org/10.1186/s12879-021-06147-y. , 2021

Link: https://doi.org/10.1186/..